Phase II multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy of HB-200 in patients with detectable TTMV-HPV DNA after definitive treatment for HPV16 + HNSCC Meeting Abstract
| Authors: | Ho, A. L.; Riaz, N.; Pfister, D.; Wong, R.; Lee, N.; Sherman, E. J.; Haque, S.; Ostrovnaya, I.; Wong, W. |
| Abstract Title: | Phase II multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy of HB-200 in patients with detectable TTMV-HPV DNA after definitive treatment for HPV16 + HNSCC |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sep 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | S652 |
| Language: | English |
| ACCESSION: | WOS:001326612901244 |
| DOI: | 10.1016/j.annonc.2024.08.1000 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 939TiP -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work